Compare Aecom (ACM) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aecom vs Ascendis Pharma A/S — how do they compare? Aecom trades at $67.13 (market cap $8.62B), while Ascendis Pharma A/S trades at $253.76 (market cap $16.67B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Aecom pays a 1.77% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ACM | ASND | |
|---|---|---|
Market Cap | $8.62B | $16.67B |
Sector | Industrials | Health |
52-Week High | $134.35 | $277.18 |
52-Week Low | $66.86 | $189.74 |
Enterprise Value | $10.81B | $17.04B |
Dividend Yield | 1.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Aecom
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
